© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 21, 1624-1632,
November 7, 2001
© 2001 Oxford University Press
ARTICLE |
Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer
Affiliations of authors: W. C. Dooley, Institute for Breast Health, University of Oklahoma Health Sciences Center, Oklahoma City; B.-M. Ljung, E. B. King (Department of Pathology), L. J. Esserman (Department of Surgery), University of California, San Francisco; U. Veronesi, M. Cazzaniga, Istituto Europeo di Oncologia, Milan, Italy; R. M. Elledge, Breast Care Center, Baylor College of Medicine, Houston, TX; J. A. O'Shaughnessy, Baylor–Sammons Cancer Center, US Oncology, Dallas, TX; H. M. Kuerer, Department of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston; D. T. Hung, Pro
Duct Health, Inc., Menlo Park, CA; S. A. Khan, Department of Surgery, Northwestern Memorial Hospital, Chicago, IL; R. F. Phillips, Metro Surgical Associates, Decatur, GA; P. A. Ganz, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; D. M. Euhus, Division of Surgical Oncology, The University of Texas Southwestern Medical Center, Dallas; B. G. Haffty, B. L. King, Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT; M. C. Kelley, Division of Surgical Oncology, Vanderbilt University Medical Center, Nashville, TN; M. M. Anderson, Department of Surgery, Martin Luther King/Charles Drew Medical Center, Los Angeles; P. J. Schmit, Department of Surgery, Olive View–University of California at Los Angeles Medical Center, Sylmar; R. R. Clark, The Breast Care Center, Santa Barbara, CA; F. C. Kass, Cancer Center of Santa Barbara; B. O. Anderson, Department of Surgery, University of Washington, Seattle; S. L. Troyan, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA; R. D. Arias, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles; J. N. Quiring, QST Consultations, Ltd., Allendale, MI; S. M. Love, University of California, Los Angeles; D. L. Page, Department of Pathology, Vanderbilt University.
Correspondence to: William C. Dooley, M.D., Institute for Breast Health, University of Oklahoma Health Sciences Center, 920 Stanton Young Blvd., Rm. WP-1140, Oklahoma City, OK 73104 (e-mail: william-dooley{at}ouhsc.edu).
Background: Breast cancer originates in breast epithelium and is associated with progressive molecular and morphologic changes. Women with atypical breast ductal epithelial cells have an increased relative risk of breast cancer. In this study, ductal lavage, a new procedure for collecting ductal cells with a microcatheter, was compared with nipple aspiration with regard to safety, tolerability, and the ability to detect abnormal breast epithelial cells. Methods: Women at high risk for breast cancer who had nonsuspicious mammograms and clinical breast examinations underwent nipple aspiration followed by lavage of fluid-yielding ducts. All statistical tests were two-sided. Results: The 507 women enrolled included 291 (57%) with a history of breast cancer and 199 (39%) with a 5-year Gail risk for breast cancer of 1.7% or more. Nipple aspirate fluid (NAF) samples were evaluated cytologically for 417 women, and ductal lavage samples were evaluated for 383 women. Adequate samples for diagnosis were collected from 111 (27%) and 299 (78%) women, respectively. A median of 13 500 epithelial cells per duct (range, 43–492 000 cells) was collected by ductal lavage compared with a median of 120 epithelial cells per breast (range, 10–74 300) collected by nipple aspiration. For ductal lavage, 92 (24%) subjects had abnormal cells that were mildly (17%) or markedly (6%) atypical or malignant (<1%). For NAF, corresponding percentages were 6%, 3%, and fewer than 1%. Ductal lavage detected abnormal intraductal breast cells 3.2 times more often than nipple aspiration (79 versus 25 breasts; McNemar's test, P<.001). No serious procedure-related adverse events were reported. Conclusions: Large numbers of ductal cells can be collected by ductal lavage to detect atypical cellular changes within the breast. Ductal lavage is a safe and well-tolerated procedure and is a more sensitive method of detecting cellular atypia than nipple aspiration.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. J. Fabian Is There a Future for Ductal Lavage? Clin. Cancer Res., August 15, 2007; 13(16): 4655 - 4656. [Full Text] [PDF]
|
|
|
|
|
|
B. Arun, V. Valero, C. Logan, K. Broglio, E. Rivera, A. Brewster, G. Yin, M. Green, H. Kuerer, Y. Gong, et al. Comparison of Ductal Lavage and Random Periareolar Fine Needle Aspiration as Tissue Acquisition Methods in Early Breast Cancer Prevention Trials Clin. Cancer Res., August 15, 2007; 13(16): 4943 - 4948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Visvanathan, D. Santor, S.Z. Ali, A. Brewster, A. Arnold, D.K. Armstrong, N.E. Davidson, and K.J. Helzlsouer The Reliability of Nipple Aspirate and Ductal Lavage in Women at Increased Risk for Breast Cancer--a Potential Tool for Breast Cancer Risk Assessment and Biomarker Evaluation Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 950 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Visvanathan, D. Santor, S. Z. Ali, I. S. Hong, N. E. Davidson, and K. J. Helzlsouer The Importance of Cytologic Intrarater and Interrater Reproducibility: the Case of Ductal Lavage Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2553 - 2556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzaniga, G. Severi, C. Casadio, L. Chiapparini, U. Veronesi, and A. Decensi Atypia and ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1311 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Antill, G. Mitchell, S. A. Johnson, L. Devereux, A. Milner, K.-A. Phillips, and I. G. Campbell Loss of Heterozygosity Analysis in Ductal Lavage Samples from BRCA1 and BRCA2 Carriers: A Cautionary Tale. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1396 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Locke, Z. Kote-Jarai, E. Bancroft, S. Bullock, S. Jugurnauth, P. Osin, A. Nerurkar, L. Izatt, G. Pichert, G. P. H. Gui, et al. Loss of Heterozygosity at the BRCA1 and BRCA2 Loci Detected in Ductal Lavage Fluid from BRCA Gene Mutation Carriers and Controls. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1399 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Dua, C. M. Isacke, and G. P.H. Gui The Intraductal Approach to Breast Cancer Biomarker Discovery J. Clin. Oncol., March 1, 2006; 24(7): 1209 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bhandare, R. Nayar, M. Bryk, N. Hou, R. Cohn, N. Golewale, N. P. Parker, R. T. Chatterton, A. Rademaker, and S. A. Khan Endocrine Biomarkers in Ductal Lavage Samples from Women at High Risk for Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2620 - 2627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lithgow and C. Covington Chronic Inflammation and Breast Pathology: A Theoretical Model Biol Res Nurs, October 1, 2005; 7(2): 118 - 129. [Abstract] [PDF]
|
|
|
|
 |
|
 W. C. Dooley Ductal Lavage: Risk Stratification Versus Cancer Detection Ann. Surg. Oncol., September 1, 2005; 12(9): 681 - 682. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Khan, J. A. Wolfman, L. Segal, S. Benjamin, R. Nayar, E. L. Wiley, M. Bryk, and M. Morrow Ductal Lavage Findings in Women With Mammographic Microcalcifications Undergoing Biopsy Ann. Surg. Oncol., September 1, 2005; 12(9): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Santen and R. Mansel Benign Breast Disorders N. Engl. J. Med., July 21, 2005; 353(3): 275 - 285. [Full Text] [PDF]
|
|
|
|
 |
|
 C J Fabian, B F Kimler, M S Mayo, and S A Khan Breast-tissue sampling for risk assessment and prevention Endocr. Relat. Cancer, June 1, 2005; 12(2): 185 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Khan, R. Nayar, E. Wiley, and M. Morrow RESPONSE: Re: Ductal Lavage Findings in Women With Known Breast Cancer Undergoing Mastectomy J Natl Cancer Inst, June 1, 2005; 97(11): 857 - 858. [Full Text] [PDF]
|
|
|
|
|
|
A. W. Kurian, M. A. Mills, M. Jaffee, B. M. Sigal, N. M. Chun, K. E. Kingham, L. C. Collins, K. W. Nowels, S. K. Plevritis, J. E. Garber, et al. Ductal Lavage of Fluid-Yielding and Non-Fluid-Yielding Ducts in BRCA1 and BRCA2 Mutation Carriers and Other Women at High Inherited Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1082 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Bean, V. Scott, L. Yee, B. Ratliff-Daniel, M. M. Troch, P. Seo, M. L. Bowie, P. K. Marcom, J. Slade, B. F. Kimler, et al. Retinoic Acid Receptor-{beta}2 Promoter Methylation in Random Periareolar Fine Needle Aspiration Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 790 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Fabian and B. F. Kimler Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer J. Clin. Oncol., March 10, 2005; 23(8): 1644 - 1655. [Full Text] [PDF]
|
|
|
|
|
|
V. Stearns, A. Gallagher, C. G. Kleer, B. Singh, M. Freedman, B. R. Haddad, C. Isaacs, R. Warren, M. Brown, J. Cullen, et al. A Pilot Study to Establish a Clinical Model to Perform Phase II Studies of Breast Cancer Chemopreventive Agents in Women at High Risk with Biomarkers as Surrogate Endpoints for Activity Clin. Cancer Res., December 15, 2004; 10(24): 8332 - 8340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Ozanne and L. J. Esserman Evaluation of Breast Cancer Risk Assessment Techniques: A Cost-effectiveness Analysis Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Stearns, A. Coop, B. Singh, A. Gallagher, H. Yamauchi, R. Lieberman, M. Pennanen, B. Trock, D. F. Hayes, and M. J. Ellis A Pilot Surrogate End Point Biomarker Trial of Perillyl Alcohol in Breast Neoplasia Clin. Cancer Res., November 15, 2004; 10(22): 7583 - 7591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Arun Ductal Lavage and Risk Assessment of Breast Cancer Oncologist, November 1, 2004; 9(6): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Fabian, B. F. Kimler, and M. S. Mayo Ductal Lavage for Early Detection--What Doesn't Come Out in the Wash J Natl Cancer Inst, October 20, 2004; 96(20): 1488 - 1489. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Khan, E. L. Wiley, N. Rodriguez, C. Baird, R. Ramakrishnan, R. Nayar, M. Bryk, K. B. Bethke, V. L. Staradub, J. Wolfman, et al. Ductal Lavage Findings in Women With Known Breast Cancer Undergoing Mastectomy J Natl Cancer Inst, October 20, 2004; 96(20): 1510 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Leonard and S. M. Swain Ductal Carcinoma In Situ, Complexities and Challenges J Natl Cancer Inst, June 16, 2004; 96(12): 906 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chatterton Jr., A. S. Geiger, S. A. Khan, I. B. Helenowski, B. D. Jovanovic, and P. H. Gann Variation in Estradiol, Estradiol Precursors, and Estrogen-related Products in Nipple Aspirate Fluid from Normal Premenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 928 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Coombes, H. A. Fritsche Jr, C. Clarke, J.-n. Chen, K. A. Baggerly, J. S. Morris, L.-c. Xiao, M.-C. Hung, and H. M. Kuerer Quality Control and Peak Finding for Proteomics Data Collected from Nipple Aspirate Fluid by Surface-Enhanced Laser Desorption and Ionization Clin. Chem., October 1, 2003; 49(10): 1615 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Sabichi, M. R. Modiano, J. J. Lee, Y.-M. Peng, M.-J. Xu, H. Villar, W. S. Dalton, and S. M. Lippman Breast Tissue Accumulation of Retinamides in a Randomized Short-term Study of Fenretinide Clin. Cancer Res., July 1, 2003; 9(7): 2400 - 2405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. King, S. C. Tsai, M. E. Gryga, T. G. D'Aquila, S. A. Seelig, L. E. Morrison, K. K. B. Jacobson, M. S. Legator, D. C. Ward, D. L. Rimm, et al. Detection of Chromosomal Instability in Paired Breast Surgery and Ductal Lavage Specimens by Interphase Fluorescence in Situ Hybridization Clin. Cancer Res., April 1, 2003; 9(4): 1509 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Kuerer, P. A. Thompson, S. Krishnamurthy, H. A. Fritsche, S. M. Marcy, G. V. Babiera, S. E. Singletary, M. Cristofanilli, N. Sneige, and K. K. Hunt High and Differential Expression of HER-2/neu Extracellular Domain in Bilateral Ductal Fluids from Women with Unilateral Invasive Breast Cancer Clin. Cancer Res., February 1, 2003; 9(2): 601 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Vogel, J. P. Costantino, D. L. Wickerham, and W. M. Cronin Re: Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst, October 2, 2002; 94(19): 1504 - 1504. [Full Text] [PDF]
|
|
|
|
|
|
C. J. Fabian, B. F. Kimler, D. A. Brady, M. S. Mayo, C. H. J. Chang, J. A. Ferraro, C. M. Zalles, A. L. Stanton, S. Masood, W. E. Grizzle, et al. A Phase II Breast Cancer Chemoprevention Trial of Oral {alpha}-Difluoromethylornithine: Breast Tissue, Imaging, and Serum and Urine Biomarkers Clin. Cancer Res., October 1, 2002; 8(10): 3105 - 3117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and W. Ki Hong Cancer Prevention by Delay : Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002. Clin. Cancer Res., February 1, 2002; 8(2): 305 - 313. [Full Text] [PDF]
|
|
|
|
|
|
J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Fabian and B. F. Kimler Breast Cancer Risk Prediction: Should Nipple Aspiration Fluid Cytology Be Incorporated Into Clinical Practice? J Natl Cancer Inst, December 5, 2001; 93(23): 1762 - 1763. [Full Text] [PDF]
|
|